South Africa | About Us | Jobs | Contact Us | Help
You are here: Home Page > Medicine & Health > Radiology > Clinical Oncology > Endocrine Therapies in Breast Cancer
128 Pages | 10 black and white illustrations
Bookseller Code (AE)
Endocrine Therapies in Breast Cancer
Edited by Aman U. Buzdar
Provides a summary of the latest evidence based and practical information on the use of endocrine therapies in the management of breast cancer
Covers an extensive range of endocrine therapies currently available to clinicians
Includes chapters on the identification and optimal selection of patients for endocrine therapy as well as the role of endocrine treatments in the prevention of breast cancer
Portable, accessible format for quick-reference
Helpful "Key Points" sections at the start of each chapter
2-colour printing throughout
Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of their disease. Tamoxifen has long been the mainstay of endocrine therapy in this group of patients. However, there is mounting evidence showing that the aromatase inhibitors are able to reduce overall oestrogen levels and appear to be better tolerated over a long term than tamoxifen. New and emerging indications for the aromatase inhibitors are providing clinicans (and patients) with alternative treatment options with differing side effect profiles.
Part of the Oxford Oncology Library, this pocketbook will summarise the latest evidence-based and practical information on the use of endrocrine therapies in the management of breast cancer (early stage, metastatic disease, and prevention of disease). With contributions from leading oncologists from the MD Anderson Cancer Center, the book covers the range of endocrine therapies currently available to clinicians including ovarian ablation, anti-estrogens, aromatase inhibitors, fulvestrant, progestins, androgens, and combination endocrine and chemotherapy. The book also includes useful chapters on the identification and optimal selection of patients for endocrine therapy as well as the role of endocrine treatments in the prevention of breast cancer.
This book will serve as an invaluable reference for all health care professionals involved in the management of patients with breast cancer.
1:Selection of patients for endocrine therapies, Dr W. Fraser Symmans and Dr Lajos Pusztai
2:Ovarian ablation, Kellie L. Jones
3:Antiestrogens, Professor John F. Forbes
4:Aromatase inhibitors in early and advanced disease, Laura B. Michaud
5:Fulvestrant - Metastatic disease, Professor John FR Roberston, Mr Kwok-Leung Cheung and Mr Amit Agrawal
6:Progestins and androgens, Janet Espirito
7:Combined endocrine and chemotherapy, Professor Aman U. Buzdar
8:Hormonal replacement therapy in patients with prior history of breast cancer, Dr Rena V. Sellin
9:Prevention, Professor Jack Cuzick
Edited by Aman U. Buzdar, Professor of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA
Mr Amit Agrawal, Research Fellow, University Medical School, Nottingham University Hospitals, Nottingham, UK
Professor Aman U. Buzdar, Professor of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA
Mr Kwok-Leung Cheung, Consultant in General Surgery, University Medical School, Nottingham, UK
Professor Jack Cuzick, Researcher, Cancer Research UK Clinical Centre at Barts and the London, London, UK
Janet Espirito, Clinical Pharmacy Specialist, University of Texas MD Anderson Cancer Center, Houston, USA
Dr Gilbert G. Fareau, Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Center, Houston, USA
Professor John F. Forbes, Professor of Surgical Oncology, University of Newcastle, New South Wales, Australia
Kellie L. Jones, Clinical Pharmacy Specialist, University of Texas MD Anderson Cancer Center, Houston, USA
Laura B. Michaud, Clinical Pharmacy Specialist, University of Texas MD Anderson Cancer Center, Houston, USA
Dr Lajos Pusztai, Associate Professor of Medicine, University of Texas MD Anderson Cancer Center, USA
Professor John FR Roberston, Consultant in General Surgery, University Medical School, Nottingham, UK
Dr Rena V. Sellin, Professor, Endocrine Neoplasia and HD, University of Texas MD Anderson Cancer Center, USA
Dr W. Fraser Symmans, Associate Professor of Pathology, University of Texas MD Anderson Cancer Center, USA
"...an excellent concise reference for physicians involved in the care of breast cancer patients." - Doody's Notes
Daniel Swinson, Matthew Seymour
The Cancer Prevention Manual
Ian Olver, Fred Stephens
Systemic Treatment of Non-Small Cell Lung Cancer
Giuseppe Giaccone
Radiotherapy in Practice - Brachytherapy
Peter Hoskin, Catherine Coyle
Systemic Treatment of Prostate Cancer
Alan Horwich
J. Mark Elwood, Simon B. Sutcliffe
Nutrition and the Cancer Patient
Egidio Del Fabbro, Eduardo Bruera, Wendy Demark-Wahnefried, Tim Bowling, Jane B. Hopkinson, Vickie E. Baracos
A Woman's Disease
Ilana Lowy
Vaccines for the Prevention of Cervical Cancer
Peter Stern, Henry Kitchener
Richard LaFond
After Prostate Cancer
Arnold Melman, Rosemary Newnham
Oxford American Mini-Handbook of Hematologic Malignancies
Gary H. Lyman
Pink Ribbon Blues
Gayle A. Sulik
Oral Complications of Cancer and its Management
Andrew Davies, Joel Epstein
Neuro-Oncology Practice
Susan Chang
Apar K. Ganti, David E. Gerber
Medicine & Health > Radiology > Clinical Oncology